Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Am J Physiol Regul Integr Comp Physiol ; 281(2): R607-14, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11448866

RESUMO

High levels of circulating catecholamines are found in the fetus, and fetal stress and birth induce a marked surge in catecholamine secretion. Little is known about the role of catecholamines on the fetal pulmonary circulation. To determine the effects of catecholamines on the pulmonary vascular tone, we tested the hemodynamic response to norepinephrine and dopamine infusion in chronically prepared late-gestation fetal lambs. We found that norepinephrine infusion (0.5 microg. kg(-1). min(-1)) increased pulmonary artery pressure (PAP) by 10 +/- 1% (P < 0.01), left pulmonary artery blood flow by 73 +/- 14% (P < 0.01), and decreased pulmonary vascular resistance (PVR) by 33 +/- 6% (P < 0.01). The pulmonary vasodilator effect of norepinephrine was abolished after nitric oxide synthase inhibition. Dopamine infusion at 5 microg. kg(-1). min(-1) did not significantly change PVR. Conversely, dopamine infusion at 10 microg. kg(-1). min(-1) increased PAP (P < 0.01) and progressively increased PVR by 30 +/- 14% (P < 0.01). These results indicate that catecholamines may modulate basal pulmonary vascular tone in the ovine fetus. We speculate that catecholamines may play a significant role in the maintenance of the fetal pulmonary circulation and in mediating changes in the transitional pulmonary circulation.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Dopamina/farmacologia , Feto/fisiologia , Norepinefrina/farmacologia , Circulação Pulmonar/fisiologia , Agonistas alfa-Adrenérgicos/farmacologia , Animais , Inibidores Enzimáticos/farmacologia , Feminino , Nitroarginina/farmacologia , Gravidez , Circulação Pulmonar/efeitos dos fármacos , Ovinos , Resistência Vascular/efeitos dos fármacos
2.
Eur J Cardiothorac Surg ; 18(3): 334-41, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10973544

RESUMO

OBJECTIVE: The purpose of this study was to examine whether inhaled nitric oxide (iNO) may change lung injury in moderate hyaline membrane disease (HMD). METHODS: Fifteen moderately premature lambs (128 days gestation, term=147 days) were randomly assigned to treatment with 20 ppm inhaled NO (n=7) from the onset of ventilation or control (n=8). Except for inhaled NO, treatments were intentionally similar to those applied in clinical situations. After porcine surfactant administration (Curosurf, 100 mg/kg), mechanical ventilator settings were modified during the course of the study to maintain PaCO(2) between 40 and 50 mmHg and post-ductal SpO(2) between 90 and 95%. The main studied parameters were gas exchanges parameters, respiratory mechanics (static compliance and functional residual capacity) and pulmonary vascular permeability and/or filtration rate indices. RESULTS: We found that 20 ppm of inhaled NO for 5 h significantly reduce ventilatory and oxygen requirements, but only during the first hour of mechanical ventilation. No increase in extravascular lung water content (5.41+/-0.96 vs. 5.46+/-1.09 ml/g bloodless dry lung in the control group and in the NO group, respectively) and no impairment of the respiratory mechanics could be found in the NO-treated group. However, inhaled NO increased the albumin lung leak index in this model (6.09+/-1.51 in the NO-treated group vs. 4.08+/-1.93 in the control group; P<0.05). CONCLUSIONS: Our results do not therefore support a detrimental effect of short-term exposure to low doses of NO inhalation in moderate HMD. However, it may induce an increase in lung vascular protein leakage. The pathophysiological consequences of this finding remain to be elucidated.


Assuntos
Sequestradores de Radicais Livres/administração & dosagem , Doença da Membrana Hialina/fisiopatologia , Pulmão/fisiopatologia , Óxido Nítrico/administração & dosagem , Troca Gasosa Pulmonar/efeitos dos fármacos , Administração por Inalação , Animais , Animais Recém-Nascidos , Gasometria , Permeabilidade Capilar/efeitos dos fármacos , Modelos Animais de Doenças , Água Extravascular Pulmonar/efeitos dos fármacos , Feminino , Humanos , Recém-Nascido , Pulmão/irrigação sanguínea , Circulação Pulmonar/fisiologia , Edema Pulmonar/fisiopatologia , Distribuição Aleatória , Respiração Artificial , Mecânica Respiratória/efeitos dos fármacos , Ovinos
4.
Biol Neonate ; 73(3): 172-81, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9535535

RESUMO

The purpose of this investigation was to examine whether inhaled nitric oxide (NO) may alter oxidative stress parameters and induce lung inflammation in moderate hyaline membrane disease (HMD). Eighteen moderately premature lambs (130 days gestation, term = 147 days) were randomly assigned to treatment with 20 ppm inhaled NO (n = 8) from the onset of ventilation or used as control (n = 10). Except inhaled NO, treatments were intentionally similar to those applied in clinical situations. The main studied parameters were oxidative stress index measurements on lung parenchyma and in circulating blood, lung parenchyma microscopic examination and bronchoalveolar lavage cell count. We found that 20 ppm of inhaled NO for 5 h did not change significantly either malondialdehyde and total antioxidant status levels in circulating blood, or malondialdehyde, reduced glutathione, glutathione peroxidase and glutathione reductase in lung parenchyma. Amino-imino-propene bond generation, which are lipoperoxidation markers, was similar in both groups. Furthermore, no significant changes in the number of inflammatory cells in lung lavage products and in lung parenchyma microscopic examination could be found. Therefore, these data do not support the hypothesis that short-term NO inhalation increases oxidative stress and lung inflammation in an experimental model of moderate HMD.


Assuntos
Animais Recém-Nascidos , Doença da Membrana Hialina/complicações , Óxido Nítrico/administração & dosagem , Estresse Oxidativo/efeitos dos fármacos , Pneumonia/induzido quimicamente , Administração por Inalação , Animais , Antioxidantes/metabolismo , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Glutationa Redutase/metabolismo , Humanos , Recém-Nascido , Peroxidação de Lipídeos , Malondialdeído/sangue , Malondialdeído/metabolismo , Óxido Nítrico/efeitos adversos , Ovinos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA